Phil Pesta
Keine laufenden Positionen mehr
Profil
Phil Pesta formerly worked at Boston Scientific Corp., as Director-Electrophysiology Division Engineering from 2009 to 2011, Embolic Protection, Inc., as Operations Director & Plant Manager, Stryker Corp., as Principal, Conceptus, Inc., as Manager-Manufacturing Engineering, AneuRx, Inc., as Manufacturing Engineer, Novare Surgical Systems, Inc., as Manufacturing Engineer, BioCardia, Inc., as Vice President-Operations, Modified Polymer Components, Inc., as Product Development Engineer, and BioCardia, Inc., as Vice President-Operations from 2011 to 2021.
Mr. Pesta received his undergraduate degree from San Jose State University.
Ehemalige bekannte Positionen von Phil Pesta
Unternehmen | Position | Ende |
---|---|---|
BIOCARDIA INC | Chief Operating Officer | 01.04.2021 |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.06.2011 |
Modified Polymer Components, Inc.
Modified Polymer Components, Inc. Medical SpecialtiesHealth Technology Modified Polymer Components, Inc. designed and manufactured custom plastic components for medical device OEMs. Its services included 3D Printing, catheter assembly solutions, development & prototyping and design & Manufacturing. The company was founded in 1989 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - |
AneuRx, Inc.
AneuRx, Inc. Medical SpecialtiesHealth Technology AneuRx, Inc. maufactures and sells surgical grafts for treating abdominal aortic aneurysms delivered via minimally invasive technologies | Corporate Officer/Principal | - |
Novare Surgical Systems, Inc.
Novare Surgical Systems, Inc. Medical SpecialtiesHealth Technology Novare Surgical Systems, Inc. manufactures and supplies surgical equipment. Its products include laparoscopic, surgical, electrosurgical instruments, surgical laser and clamps, skin markers and orthopedic appliances. The company was founded by Thomas J. Fogarty and Kerry Pope in 1999 and is headquartered in Cupertino, CA. | Corporate Officer/Principal | - |
Ausbildung von Phil Pesta
San Jose State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
STRYKER CORPORATION | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Distribution Services |
BIOCARDIA INC | Health Technology |
Private Unternehmen | 6 |
---|---|
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Health Technology |
AneuRx, Inc.
AneuRx, Inc. Medical SpecialtiesHealth Technology AneuRx, Inc. maufactures and sells surgical grafts for treating abdominal aortic aneurysms delivered via minimally invasive technologies | Health Technology |
Embolic Protection, Inc.
Embolic Protection, Inc. Medical DistributorsDistribution Services Embolic Protection, Inc. develops proprietary filters that capture embolic material that is dislodged during cardiovascular surgery. | Distribution Services |
Novare Surgical Systems, Inc.
Novare Surgical Systems, Inc. Medical SpecialtiesHealth Technology Novare Surgical Systems, Inc. manufactures and supplies surgical equipment. Its products include laparoscopic, surgical, electrosurgical instruments, surgical laser and clamps, skin markers and orthopedic appliances. The company was founded by Thomas J. Fogarty and Kerry Pope in 1999 and is headquartered in Cupertino, CA. | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
Modified Polymer Components, Inc.
Modified Polymer Components, Inc. Medical SpecialtiesHealth Technology Modified Polymer Components, Inc. designed and manufactured custom plastic components for medical device OEMs. Its services included 3D Printing, catheter assembly solutions, development & prototyping and design & Manufacturing. The company was founded in 1989 and was headquartered in Sunnyvale, CA. | Health Technology |